SINOVAC upholds a diversified product pipeline and a continuous process of innovation to support its aims to develop safer and more effective vaccines that provide protection from disease for all people, everywhere. SINOVAC's vaccine products and R&D pipeline cover a range of infectious and major diseases, including but not limited to vaccines for hand, foot and mouth disease, meningitis, pertussis, pneumococcus, rabies, and rotavirus; as well as multiple vaccines under development with major clinical trials.